The N6-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy

被引:342
|
作者
Dorn, Lisa E. [1 ]
Lasman, Lior [3 ]
Chen, Jing [4 ]
Xu, Xianyao [2 ]
Hund, Thomas J. [2 ]
Medvedovic, Mario [4 ]
Hanna, Jacob H. [3 ]
van Berlo, Jop H. [5 ,6 ]
Accornero, Federica [1 ]
机构
[1] Ohio State Univ, Dept Physiol & Cell Biol, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Biomed Engn, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA
[3] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel
[4] Univ Cincinnati, Dept Environm Hlth, Div Biostat & Bioinformat, Cincinnati, OH 45221 USA
[5] Univ Minnesota, Div Cardiovasc, Lillehei Heart Inst, Minneapolis, MN 55455 USA
[6] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA
基金
英国医学研究理事会; 以色列科学基金会; 美国国家卫生研究院; 欧洲研究理事会;
关键词
gene expression profiling; hypertrophy; mice; transgenic; RNA processing; post-transcriptional; GENE-EXPRESSION; NUCLEAR-RNA; GROWTH; N6-METHYLADENOSINE;
D O I
10.1161/CIRCULATIONAHA.118.036146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:N-6-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. The role of m6A mRNA methylation in the heart is not known. Methods: To determine the role of m6A methylation in the heart, we isolated primary cardiomyocytes and performed m6A immunoprecipitation followed by RNA sequencing. We then generated genetic tools to modulate m6A levels in cardiomyocytes by manipulating the levels of the m6A RNA methylase methyltransferase-like 3 (METTL3) both in culture and in vivo. We generated cardiac-restricted gain- and loss-of-function mouse models to allow assessment of the METTL3-m6A pathway in cardiac homeostasis and function. Results: We measured the level of m6A methylation on cardiomyocyte mRNA, and found a significant increase in response to hypertrophic stimulation, suggesting a potential role for m6A methylation in the development of cardiomyocyte hypertrophy. Analysis of m6A methylation showed significant enrichment in genes that regulate kinases and intracellular signaling pathways. Inhibition of METTL3 completely abrogated the ability of cardiomyocytes to undergo hypertrophy when stimulated to grow, whereas increased expression of the m6A RNA methylase METTL3 was sufficient to promote cardiomyocyte hypertrophy both in vitro and in vivo. Finally, cardiac-specific METTL3 knockout mice exhibit morphological and functional signs of heart failure with aging and stress, showing the necessity of RNA methylation for the maintenance of cardiac homeostasis. Conclusions: Our study identified METTL3-mediated methylation of mRNA on N-6-adenosines as a dynamic modification that is enhanced in response to hypertrophic stimuli and is necessary for a normal hypertrophic response in cardiomyocytes. Enhanced m6A RNA methylation results in compensated cardiac hypertrophy, whereas diminished m6A drives eccentric cardiomyocyte remodeling and dysfunction, highlighting the critical importance of this novel stress-response mechanism in the heart for maintaining normal cardiac function.
引用
收藏
页码:533 / 545
页数:13
相关论文
共 50 条
  • [1] The N6-Methyladenosine Methylase Wtap is Essential for Cardiac Homeostasis
    Han, Ziqiang
    Zou, Yubao
    Li, Shuai
    Lu, Minjie
    Nie, Yu
    Song, Lei
    Wang, Jizheng
    CIRCULATION, 2022, 146
  • [2] N6-Methyladenosine methylase METTL3 contributes to neuropathic pain by epigenetic silencing of mu opioid receptor
    Chen, Yao
    Han, Yakun
    Liu, Li
    Liu, Minqiang
    Lin, Jing
    Tang, Yi
    Guo, Shanshan
    He, Renliang
    Wu, Qiang
    BEHAVIOURAL BRAIN RESEARCH, 2023, 452
  • [3] N6-methyladenosine modification and METTL3 modulate enterovirus 71 replication
    Hao, Haojie
    Hao, Sujuan
    Chen, Honghe
    Chen, Zhen
    Zhang, Yanfang
    Wang, Jun
    Wang, Hanzhong
    Zhang, Bo
    Qiu, Jianming
    Deng, Fei
    Guan, Wuxiang
    NUCLEIC ACIDS RESEARCH, 2019, 47 (01) : 362 - 374
  • [4] Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis
    Zhou, Yaqing
    Jiang, Rongli
    Jiang, Yali
    Fu, Yahong
    Manafhan, Yerbolat
    Zhu, Jinfu
    Jia, Enzhi
    CELLS, 2022, 11 (19)
  • [5] METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma
    Zhijin Zhang
    Jun Fu
    Yuhao Zhang
    Xianju Qin
    Yuexia Wang
    Chungen Xing
    BMC Gastroenterology, 23
  • [6] METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma
    Zhang, Zhijin
    Fu, Jun
    Zhang, Yuhao
    Qin, Xianju
    Wang, Yuexia
    Xing, Chungen
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [7] The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells
    Vu, Ly P.
    Pickering, Brian F.
    Cheng, Yuanming
    Zaccara, Sara
    Diu Nguyen
    Minuesa, Gerard
    Chou, Timothy
    Chow, Arthur
    Saletore, Yogesh
    MacKay, Matthew
    Schulman, Jessica
    Famulare, Christopher
    Patel, Minal
    Klimek, Virginia M.
    Garrett-Bakelman, Francine E.
    Melnick, Ari
    Carroll, Martin
    Mason, Christopher E.
    Jaffrey, Samie R.
    Kharas, Michael G.
    NATURE MEDICINE, 2017, 23 (11) : 1369 - +
  • [8] Multifaceted Roles of the N6-Methyladenosine RNA Methyltransferase METTL3 in Cancer and Immune Microenvironment
    Hu, Chenxi
    Liu, Jiacheng
    Li, Yue
    Jiang, Wei
    Ji, Ding
    Liu, Wei
    Ma, Teng
    BIOMOLECULES, 2022, 12 (08)
  • [9] The piRNA CHAPIR regulates cardiac hypertrophy by controlling METTL3-dependent N6-methyladenosine methylation of Parp10 mRNA
    Xiang-Qian Gao
    Yu-Hui Zhang
    Fang Liu
    Murugavel Ponnusamy
    Xue-Mei Zhao
    Lu-Yu Zhou
    Mei Zhai
    Cui-Yun Liu
    Xin-Min Li
    Man Wang
    Chan Shan
    Pei-Pei Shan
    Yin Wang
    Yan-Han Dong
    Li-Li Qian
    Tao Yu
    Jie Ju
    Tao Wang
    Kai Wang
    Xin-Zhe Chen
    Yun-Hong Wang
    Jian Zhang
    Pei-Feng Li
    Kun Wang
    Nature Cell Biology, 2020, 22 : 1319 - 1331
  • [10] The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells
    Ly P Vu
    Brian F Pickering
    Yuanming Cheng
    Sara Zaccara
    Diu Nguyen
    Gerard Minuesa
    Timothy Chou
    Arthur Chow
    Yogesh Saletore
    Matthew MacKay
    Jessica Schulman
    Christopher Famulare
    Minal Patel
    Virginia M Klimek
    Francine E Garrett-Bakelman
    Ari Melnick
    Martin Carroll
    Christopher E Mason
    Samie R Jaffrey
    Michael G Kharas
    Nature Medicine, 2017, 23 : 1369 - 1376